Optimization of Acute Treatment in First Episode Schizophrenia

PHASE4UnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 30, 2000

Study Completion Date

December 31, 2004

Conditions
Schizophrenia, First-Episode
Interventions
DRUG

Risperidone, Haloperidol

Trial Locations (1)

80336

Department of Psychiatry, Ludwig-Maximilians-University, Munich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Janssen-Cilag Ltd.

INDUSTRY

collaborator

German Research Network On Schizophrenia

NETWORK

collaborator

Department of Psychiatry University of Bonn

OTHER

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

collaborator

Department of Psychiatry University FU Berlin

OTHER

collaborator

University of Göttingen

OTHER

collaborator

University of Cologne

OTHER

collaborator

Mainz University

OTHER

collaborator

University Hospital Tuebingen

OTHER

collaborator

Universität Duisburg-Essen

OTHER

collaborator

University of Mannheim

OTHER

collaborator

University of Jena

OTHER

collaborator

Martin-Luther-Universität Halle-Wittenberg

OTHER

collaborator

RWTH Aachen University

OTHER

collaborator

University of Wuerzburg

OTHER

lead

Ludwig-Maximilians - University of Munich

OTHER

NCT00157378 - Optimization of Acute Treatment in First Episode Schizophrenia | Biotech Hunter | Biotech Hunter